Michel Ducreux
15PUBLICATIONS
103CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé
|Jan 10, 2026
The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma.Elissar Moujaes, Jules Dupont, Littisha Lawrance
|Dec 10, 2025
Anti-Epidermal Growth Factor Receptor Therapy in EGFR-Amplified Esophagogastric Cancers: An Underestimated Efficacy.Marine Valéry, Damien Vasseur, Alexandre Megherbi
|Dec 04, 2025
Reply to: "FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies," "Conversion Chemotherapy for Locally Advanced Pancreatic Carcinoma: FOLFIRINOX or Gemcitabine?," and "Chemotherapy for Locally Advanced Pancreatic Cancer: The Dilemma of David Versus Goliath After NEOPAN".Michel Ducreux, Matthieu Texier, Olivier Bouche
|Aug 06, 2025
Collagenous colitis in patients treated for cancer: role of immune checkpoint inhibitors. Clinical, histological and immunological features in 15 cases.Mohamed-Amine Bani, Peggy Dartigues, Ranya Soufan
|May 16, 2025
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.Michel Ducreux, Romain Desgrippes, Yves Rinaldi
Pageof 3
Frequent Collaborators
5 joint publications
Antoine Hollebecque
3 joint publications
Alice Boilève
3 joint publications
Thomas Pudlarz
2 joint publications
David Malka
2 joint publications
Jean-Philippe Metges
2 joint publications
Rosine Guimbaud
2 joint publications
Anthony Tarabay
2 joint publications
Fanny Jaulin
2 joint publications
Jean-Yves Scoazec
2 joint publications
Lambros Tselikas
